Science Validation of Glyconutrients:

As you will see below, a number of well respected scientific publications have recognized our technology. In addition to the numerous scientific publications listed below, there are a number of resources on the internet that further validate the science behind our products. We would encourage you to take a serious look at the amount of scientific proof available.

NEWS in 2003 - Technology Review: MIT's Magazine of Innovation - The first innovation is Glycomics - the study of sugars for cellular communication. Article Title: 10 Emerging Technologies That Will Change the World.

Must read for someone fighting cancer: Cancer fraud?       Harpers Biochemistry, a medical textbook that has been educating healthcare professionals about Glyconutrients and their role in health and healing since 1996. From a clinical perspective, one class of nutrients absolutely necessary for optimal cellular communication and which is essentially missing from our food supply is glyconutrients. These are necessary carbohydrates (monosaccharides) that according to the 1996 edition of Harper's Biochemistry, only 2 or 3 of the necessary 8 are commonly found in our diet. These monosaccharides provide the necessary building blocks that enable the cells of our body to communicate effectively. Physician's Desk Reference (PDR) for Nonprescription Drugs and Dietary Supplements is used by 99% of all doctors and healthcare professionals before recommending solutions to their patients. Glyconutrients are listed for compromised immune systems. Acta Anatomica ~ Glycosciences, Issue 161/1-April 1998 International Journal of Anatomy, Embryology and Cell Biology. "Glycosylation is the most common form of protein and lipid modification but its biological significance has long been underestimated. The last decade, however, has witnessed the rapid emergence of the concept of the sugar code of biological information. Mono-saccharides represent an alphabet of biological information similar to amino acids and nucleic acids but with unsurpassed coding capacity."   Science Magazine, Special Issue ~ Carbohydrates & Glycobiology, March 23, 2001. This premier journal for researchers and scientists recently dedicated an entire issue to educating the science and medical community about Glyconutrients, Glycobiology and Glycoscience. Scientific American ~ Medicine, Jan. 22, 2002. "Changing Cancer Cells' 'Surface Sugars' Can Inhibit Tumor Growth." "The key to halting cancer cells may lie in their sugary coats", scientists say. Carbohydrate molecules surround all cells and help them to identify and interact with one another. Now new research, published today in the Proceedings of the National Academy of Sciences, indicates that altering some of the surface sugars associated with cancer cells can control tumor growth. The findings suggest that the sugars could one day serve as targets for new anti-cancer therapies.   MIT's Technology Review ~October 2001. "Sugars Could be Biology's Next Sweet Spot." Technology Review promotes the understanding of emerging technologies and their impact on business and society. In this issue the magazine emphasizes the next field of biology is waiting to break out: glycomics. This emerging discipline seeks move sugars and carbohydrates into the mainstream of biomedical research and drug discovery. Scientific American ~ July 2002. "Sweet Medicine: Building Better Drugs from Sugars." Sugars play critical roles in many cellular functions and in disease. Study of those activities lags behind research into genes and proteins but is beginning to heat up. The discoveries promise to yield a new generation of drug therapies. Committee of Government Reform: Comprehensive Medical Care for Bioterrorism Exposure. In November, 2001 we were the only nutritional company on Earth asked by Congress to speak on Bio Terrorism & the evidence supporting the potential for glyconutrients and micronutrient dietary supplementation to support natural defense and healing mechanisms to ameliorate bacterial, viral and fungal infections due to the outstanding results of our products on the human immune system. The Medical director of our company, Dr H. Reg McDaniel, MD made the presentation. Trademark Office. Our company's proprietary technology is both patented and patent pending throughout the world. We were the only nutritional company out of 12 companies examined worldwide by the United States Patent and Trademark Office at their 3 day technology fair in 2001 asked to present new technology and discoveries. All companies were pharmaceutical drug companies with the exception of ours. We were the only nutritional company on the globe asked to be present out of this outstanding list of presenters. The purpose of the presentation was to educate more than 400 senior patent examiners on current cutting-edge technology for which they review patents. Nugent Report. A scientific review of Glyconutritional Dietary Supplements. Doctor Nugent has spoken to over a hundred fifty thousand people in a year including all disciplines of science and medicine, drawing upon his extensive background of over twenty years of intensive research and practice in the field of natural medicines. He is president of the International Association of Complementary Medicine. M.D. News, ~ June 2002. M.D. News, a national publication with regionalized editions in 40 major medical markets in the U.S. This 3-page article covers the science of sugars and reviews specific topics such as successes with fibromyalgia, toxic shock and diabetes. Advance for Managers of Respiratory Care, July/August 2002. Feature article entitled "Glyconutrients Could Offer Novel Approach to Asthma." American Nutraceutical Association Providing quality education to health care professionals, consumers and manufacturers involved in the emerging nutraceutical industry. Fisher Institute for Medical Research Fisher Institute for Medical Research seeks to promote wellness by providing research into the benefits of glyconutrients, phytochemicals, and functional foods.